A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, a first adhesive layer disposed on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a second adhesive layer disposed over the first adhesive layer and configured to provide a sealing engagement between the body and the urethral meatus, wherein the second adhesive layer is removable from the first adhesive layer.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, a first adhesive layer disposed on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a second adhesive layer disposed over the first adhesive layer and configured to provide a sealing engagement between the body and the urethral meatus, wherein the second adhesive layer is removable from the first adhesive layer.

A dressing for treating a tissue site with negative pressure may comprise a cover having an adhesive, a manifold, a perforated polymer film, and a perforated silicone gel having a treatment aperture. The cover, the manifold, the perforated polymer film, and the perforated silicone gel may be assembled in a stacked relationship with the cover and the perforated silicone gel enclosing the manifold. The perforated polymer film may be at least partially exposed through the treatment aperture, and at least some of the adhesive may be exposed through the perforated silicone around the treatment aperture.

A dressing for treating a tissue site with negative pressure may comprise a cover having an adhesive, a manifold, a perforated polymer film, and a perforated silicone gel having a treatment aperture. The cover, the manifold, the perforated polymer film, and the perforated silicone gel may be assembled in a stacked relationship with the cover and the perforated silicone gel enclosing the manifold. The perforated polymer film may be at least partially exposed through the treatment aperture, and at least some of the adhesive may be exposed through the perforated silicone around the treatment aperture.

Devices, kits and methods described herein include skin treatments with a book-like packaging, applicator and/or tensioning device used to apply a dressing to a subject. The packaging, applicator and/or tensioning device is used to apply and/or maintain a strain in an elastic dressing, and has a first support, a second support, and a primary bending region therebetween, the primary bending region comprising a primary bending axis, with the dressing attached to the first and second supports of the device.

Devices, kits and methods described herein include skin treatments with a book-like packaging, applicator and/or tensioning device used to apply a dressing to a subject. The packaging, applicator and/or tensioning device is used to apply and/or maintain a strain in an elastic dressing, and has a first support, a second support, and a primary bending region therebetween, the primary bending region comprising a primary bending axis, with the dressing attached to the first and second supports of the device.

Devices, kits and methods described herein include skin treatments with a book-like packaging, applicator and/or tensioning device used to apply a dressing to a subject. The packaging, applicator and/or tensioning device is used to apply and/or maintain a strain in an elastic dressing, and has a first support, a second support, and a primary bending region therebetween, the primary bending region comprising a primary bending axis, with the dressing attached to the first and second supports of the device.

A fibrous layer, wherein surface of the fibres has surface energy below 50 mN/m, characterised in that the calculated strike through time coefficient (cSTT) of the fibrous layer is below 20 and the fibrous layer is bonded in its entire volume at fibre to fibre contact bonding points, wherein the specific fibre surface is the surface area of the fibres in m.sup.2 per 1 m.sup.2 of the fibrous layer, basis weight is the weight of the layer in kg per 1 m.sup.2 of the fibrous layer, the specific void volume is the volume of empty spaces between the fibres in m.sup.3 per 1 m.sup.2 of the fibrous layer.

[00001]$\mathrm{cSTT}=\frac{{\left(\mathrm{specific}\mathrm{fibre}\mathrm{surface}\right)}^2\times \left(\mathrm{basis}\mathrm{weight}\right)}{\left(\mathrm{specific}\mathrm{void}\mathrm{volume}\right)\times {\left(\mathrm{surface}\mathrm{energy}\mathrm{of}\mathrm{fibre}\mathrm{surface}\right)}^3}\times 600$

A fibrous layer, wherein surface of the fibres has surface energy below 50 mN/m, characterised in that the calculated strike through time coefficient (cSTT) of the fibrous layer is below 20 and the fibrous layer is bonded in its entire volume at fibre to fibre contact bonding points, wherein the specific fibre surface is the surface area of the fibres in m.sup.2 per 1 m.sup.2 of the fibrous layer, basis weight is the weight of the layer in kg per 1 m.sup.2 of the fibrous layer, the specific void volume is the volume of empty spaces between the fibres in m.sup.3 per 1 m.sup.2 of the fibrous layer.

[00001]$\mathrm{cSTT}=\frac{{\left(\mathrm{specific}\mathrm{fibre}\mathrm{surface}\right)}^2\times \left(\mathrm{basis}\mathrm{weight}\right)}{\left(\mathrm{specific}\mathrm{void}\mathrm{volume}\right)\times {\left(\mathrm{surface}\mathrm{energy}\mathrm{of}\mathrm{fibre}\mathrm{surface}\right)}^3}\times 600$

Compositions-of-matter comprising a matrix made of one or more, preferably two or more elastic layers and one or more viscoelastic layer are disclosed. The compositions-of-matter are characterized by high water-impermeability and optionally by self-recovery. Processes of preparing the compositions-of-matter and uses thereof as tissue substitutes or for repairing damaged tissues are also disclosed.